問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberTTYTG0702

2007-07-02 - 2012-06-30

Phase III

Terminated11

  • Trial Applicant

    TTY Biopharm Company Limited

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Jin-Hwang Liu Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 謝瑞坤 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Jen-Shi Chen Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 饒坤銘 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Wu-Chou Su Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Chang-Fang Chiu Division of Hematology & Oncology

Co-Principal Investigator

  • 黃馨慧 Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 張正雄 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Sheng-Fung Lin Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 謝瑞坤 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    60 participants

  • Global

    750 participants